Izervay Alternatives Compared
| Izervay (avacincaptad pegol) | Syfovre (pegcetacoplan) | Pegcetacoplan ophthalmic |
|
|---|
| Izervay (avacincaptad pegol) | Syfovre (pegcetacoplan) | Pegcetacoplan ophthalmic |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Geographic Atrophy, Macular Degeneration. Izervay may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Macular Degeneration, Geographic Atrophy. Syfovre may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Macular Degeneration, Geographic Atrophy. Pegcetacoplan ophthalmic may also be used for purposes not listed in this medication guide. |
Related suggestions Macular Degeneration
Geographic Atrophy
|
|||||||||||||||
| More about Izervay (avacincaptad pegol) | More about Syfovre (pegcetacoplan) | More about Pegcetacoplan ophthalmic | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Izervay has an average rating of 6.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 0% reported a negative effect. |
Syfovre has an average rating of 9.3 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Pegcetacoplan ophthalmic has an average rating of 9.3 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Izervay prices |
View all Syfovre prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
N/A |
Syfovre | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
288 hours |
108 hours |
108 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 2 drugs are known to interact with Syfovre:
|
A total of 2 drugs are known to interact with Pegcetacoplan ophthalmic:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.